Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease

被引:79
作者
Abenavoli, Ludovico [1 ]
Peta, Valentina [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa, I-88100 Catanzaro, Italy
关键词
Adipokines; cytokines; fibrosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; steatosis;
D O I
10.2174/1574887109666141216102458
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
One of the most common hepatic manifestations of the metabolic syndrome is non-alcoholic fatty liver disease (NAFLD). This disease varies from simple steatosis to cirrhosis and hepatocellular carcinoma. Different molecules secreted from adipose tissue such as adiponectin, leptin, resistin and visfatin and pro-inflammatory cytokines such as tumour necrosis factor-alpha, and interleukins, can be involved in the pathogenesis of NAFLD. In this review we describe the role of these adipokines and cytokines in the pathogenesis of NAFLD. We comment on their potential use as non-invasive biomarkers of steatosis and fibrosis, and their potential therapeutic role.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 92 条
  • [1] Abenavoli L, 2014, PANMINERVA MED, V56, P189
  • [2] Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori
    Abenavoli, Ludovico
    Milic, Natasa
    Masarone, Mario
    Persico, Marcello
    [J]. MEDICAL HYPOTHESES, 2013, 81 (05) : 913 - 915
  • [3] Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
    Abenavoli, Ludovico
    Bellentani, Stefano
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (08) : 677 - 679
  • [4] Abenavoli Ludovico, 2011, Metabolism, V60, pe3, DOI 10.1016/j.metabol.2011.08.002
  • [5] Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
    Abiru, S
    Migita, K
    Maeda, Y
    Daikoku, M
    Ito, M
    Ohata, K
    Nagaoka, S
    Matsumoto, T
    Takil, Y
    Kusumoto, K
    Nakamura, M
    Komori, A
    Yano, K
    Yatsuhashi, H
    Eguchi, K
    Ishibashi, H
    [J]. LIVER INTERNATIONAL, 2006, 26 (01) : 39 - 45
  • [6] Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease
    Aller, Rocio
    de Luis, Daniel A.
    Fernandez, Luis
    Calle, Fernando
    Velayos, Benito
    Olcoz, Jose Luis
    Izaola, Olatz
    Gonzalez Sagrado, Manuel
    Conde, Rosa
    Manuel Gonzalez, Jose
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (04) : 1088 - 1092
  • [7] Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity (Reprinted from BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol 257, pg 79-83, 1999)
    Arita, Yukio
    Kihara, Shinji
    Ouchi, Noriyuki
    Takahashi, Masahiko
    Maeda, Kazuhisa
    Miyagawa, Jun-ichiro
    Hotta, Kikuko
    Shimomura, Iichiro
    Nakamura, Tadashi
    Miyaoka, Koji
    Kuriyama, Hiroshi
    Nishida, Makoto
    Yamashita, Shizuya
    Okubo, Kosaku
    Matsubara, Kenji
    Muraguchi, Masahiro
    Ohmoto, Yasuichi
    Funahashi, Tohru
    Matsuzawa, Yuji
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (03) : 560 - 564
  • [8] Insulin resistance in type 2 diabetes - Role of the adipokines
    Arner, P
    [J]. CURRENT MOLECULAR MEDICINE, 2005, 5 (03) : 333 - 339
  • [9] Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
    Bedogni, G
    Miglioli, L
    Masutti, F
    Tiribelli, C
    Marchesini, G
    Bellentani, S
    [J]. HEPATOLOGY, 2005, 42 (01) : 44 - 52
  • [10] Incidence and natural course of fatty liver in the general population: the dionysos study
    Bedogni, Giorgio
    Miglioli, Lucia
    Masutti, Flora
    Castiglione, Anna
    Croce, Lory Saveria
    Tiribelli, Claudio
    Bellentani, Stefano
    [J]. HEPATOLOGY, 2007, 46 (05) : 1387 - 1391